About Apna Chemist
Apna Chemist is a Healthcare company based in Gurugram (India) founded in 2018 by Aman Nagar. Apna Chemist has raised $213.03 thousand across 1 funding round from investors including Arjun Juneja. The company has 171 employees. Apna Chemist was last valued at $21.54 million in December 2021. Its Indian entity Genitech Vnsan Pharmaceuticals Private Limited reported revenue of ₹4.80 Cr. Apna Chemist offers products and services including Medicine Delivery Service, Chronic Diseases Medicines, Non-Chronic Medicines, Ayurvedic Medicines, and Nutrition and Dietics. Its focus areas include HealthTech, Healthcare Booking Platforms, Pharmacies and Drugs. Its competitors include Tata 1mg, Netmeds and Truemeds; 3 of its 3 listed competitors have raised funding.
Company details
Online pharmacy offers a variety of healthcare products. The company offers a variety of healthcare products, including medicines such as homeopathy, ayurveda, naturopathy, Siddha, Unani, and yoga. The company also provides OTC products, FMCG products, healthcare products, and devices.
- Headquarters Gurugram, India
- Employees 171
- Founders Aman Nagar
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website apnachemist.com
- Social LinkedIn X Facebook
- Legal Name Genitech Vnsan Pharmaceuticals Private Limited
- Date of Incorporation 17 Dec, 2018
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹4.80 Cr
FY 2026 · -78% YoY
- Net Profit₹3.11 Cr
FY 2026 · 65% margin
- EBITDA₹3.84 Cr
FY 2026 · 80% margin
- Total Equity Funding$213.03K (USD)
in 1 rounds
- Latest Funding Round$213.03K (USD), Angel Round
Dec 2021
- Employee Count171
Associated legal entities of Apna Chemist
Apna Chemist operates through Genitech Vnsan Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Genitech Vnsan Pharmaceuticals Private Limited CIN U52609DL2018PTC343129 | Active | 17 Dec 2018 | New Delhi, Delhi | ₹4.8 Cr | 171 | 3 | View details |
Products & Services of Apna Chemist
Apna Chemist offers a comprehensive portfolio of products and services, including Medicine Delivery Service, Chronic Diseases Medicines, Non-Chronic Medicines, Ayurvedic Medicines, and Nutrition and Dietics.
App for uploading prescriptions and receiving medicines quickly
Range of treatments for long-term health conditions
Medications for short-term ailments and relief
Herbal and traditional remedies for wellness
Products for dietary support and health maintenance
Items for skin care and daily personal needs
Essentials for infant nutrition and care
Apps and channels of Apna Chemist
Apna Chemist publishes 1 mobile app with over 100 downloads.
Funding Insights of Apna Chemist
Apna Chemist has successfully raised a total of $213.03K through 1 strategic funding round. The most recent funding activity was a Angel Round of $213.03 thousand completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $213,030
- Total Rounds 1
- Last Round Angel Round — $213,030
- First Round $213,030
(Dec 2021)
- Investors Count 1
All 1 funding rounds of Apna Chemist with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2021 | $213,030 | Angel Round | $21.54M | Arjun Juneja | – |
| Date | Valuation | Stage |
|---|---|---|
| Dec 2021 | $21.54M | •••••••• |
Last known valuation $21.54M (Dec 2021). 1 investors in total: 0 institutional and 1 angel.
Investors in Apna Chemist
Apna Chemist has secured backing from 1 investor, including angel investors. Prominent investors backing the company include Arjun Juneja.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
AJ Arjun Juneja | unknown_4f6ce8c55905436cb |
Investor details for Apna Chemist
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Genitech Vnsan Pharmaceuticals Private Limited (Apna Chemist)
Genitech Vnsan Pharmaceuticals Private Limited is the primary company behind Apna Chemist. The board of Genitech Vnsan Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Deepak Kumar, appointed in 2023. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Deepak Kumar DIN 10183851 | Director | 01 Jun 2023 | 3 yrs 5 mo | Genitech Vnsan Pharmaceuticals Private Limited |
| Vijay Kumar Verma DIN 10948118 | Additional Director | 11 Sep 2025 | 1 yr 1 mo | Genitech Vnsan Pharmaceuticals Private Limited |
| Atul Kumar DIN 08500923 | Additional Director | 01 Nov 2025 | 11 mo | Genitech Vnsan Pharmaceuticals Private Limited |
People of Apna Chemist
1 people are tracked at Apna Chemist (1 in leadership); the tracked headcount is 171.
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership |
Complete people profiles for Apna Chemist
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Apna Chemist
Figures of Genitech Vnsan Pharmaceuticals Private Limited, the primary company behind Apna Chemist, for FY 2026. Revenue was ₹4.80 Cr (-78% year on year). Net profit was ₹3.11 Cr (65% margin). EBITDA was ₹3.84 Cr (80% margin). Revenue has grown at a compounded annual rate of -49% over three years and -17% over five years.
- ₹4.80 CrRevenue · FY 2026 · -78% YoY
- ₹3.11 CrNet profit · 65% margin
- ₹3.84 CrEBITDA · 80% margin
- ₹1 LakhPaid-up capital
- 171Employees (provident fund records)
- -49%Revenue CAGR, 3 years
- -17%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Genitech Vnsan Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Apna Chemist
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Apna Chemist
3 dated milestones of Apna Chemist across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Apna Chemist is founded.
- Funding First funding round of $213K.
- Milestone Reaches Minicorn status.
Competitors of Apna Chemist
Apna Chemist has 3 listed competitors in our database, 3 of them funded. They include Tata 1mg, Netmeds and Truemeds.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| 1mg.com | 2015 | Delhi, India | $230.8M | 4,419 | Provider of an online pharmacy with doctor listing and teleconsultation services | |
| netmeds.com | 2015 | Chennai, India | $109M | 988 | Provider of an online store for medicines and healthcare products | |
| truemeds.in | 2019 | Mumbai, India | $112.97M | 345 | Provider of an online pharmacy and telehealth platform |
Detailed competitors of Apna Chemist
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Digital Health & Telemedicine
3 companies that operate in the same segment as Apna Chemist (Digital Health & Telemedicine) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of an online pharmacy with doctor listing and teleconsultation services | 2015 | Delhi, Delhi, India | USD 199.65 M | USD 328.97 M | 5,212 | |
Online platform offering multiple healthcare services | 2013 | Bengaluru, Karnataka, India | USD 199.22 M | USD 62.4 M | 52 | |
An online marketplace for healthcare products is operated. | 2011 | Kolkata, West Bengal, India | USD 38.26 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Apna Chemist
Apna Chemist was founded in 2018 and raised its 1st funding round 3 years after it was founded.
Apna Chemist is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.
Apna Chemist is a funded company, having raised a total of $213.03K across 1 funding round to date. The company's 1st funding round was a Angel Round of $213.03K, raised on Dec 2021.
Apna Chemist has 171 employees.
The primary company behind Apna Chemist, Genitech Vnsan Pharmaceuticals Private Limited, reported revenue of ₹4.80 Cr for FY 2026, down 78% year on year.
Online pharmacy offers a variety of healthcare products. The company offers a variety of healthcare products, including medicines such as homeopathy, ayurveda, naturopathy, Siddha, Unani, and yoga. The company also provides OTC products, FMCG products, healthcare products, and devices.
Apna Chemist offers Medicine Delivery Service, Chronic Diseases Medicines, Non-Chronic Medicines, Ayurvedic Medicines, and 3 more products and services.
Apna Chemist has 1 investor. Key investors include Arjun Juneja.
The valuation of Apna Chemist is $21.54M as of Dec 2021.
Apna Chemist operates through Genitech Vnsan Pharmaceuticals Private Limited.
The legal entities of Apna Chemist currently have 3 directors, including Atul Kumar, Deepak Kumar, Vijay Kumar Verma.